GD
SNY icon

Grandfield & Dodd’s Sanofi SNY Stock Holding History

Grandfield & Dodd’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
384,643
-2,587
-0.7% -$116K 0.86% 40
2026
Q1 		$18.7M Buy
387,230
+5,865
+2% +$273K 1.05% 35
2025
Q4 		$18.5M Sell
381,365
-12,512
-3% -$620K 1.05% 35
2025
Q3 		$18.6M Buy
393,877
+8,689
+2% +$419K 1.05% 35
2025
Q2 		$18.6M Sell
385,188
-2,742
-0.7% -$140K 1.09% 32
2025
Q1 		$21.5M Sell
387,930
-1,555
-0.4% -$84.2K 1.33% 26
2024
Q4 		$18.8M Sell
389,485
-95
-0% -$4.83K 1.16% 33
2024
Q3 		$22.5M Buy
389,580
+20
+0% +$1.08K 1.33% 28
2024
Q2 		$18.9M Buy
389,560
+3,069
+0.8% +$148K 1.2% 32
2024
Q1 		$18.8M Buy
386,491
+4,513
+1% +$220K 1.19% 32
2023
Q4 		$19M Buy
381,978
+5,600
+1% +$274K 1.31% 31
2023
Q3 		$20.2M Buy
376,378
+5,055
+1% +$270K 1.48% 26
2023
Q2 		$20M Sell
371,323
-1,916
-0.5% -$103K 1.4% 27
2023
Q1 		$20.3M Buy
373,239
+5,395
+1% +$262K 1.42% 28
2022
Q4 		$17.8M Buy
367,844
+27,918
+8% +$1.23M 1.3% 33
2022
Q3 		$12.9M Buy
339,926
+1,326
+0.4% +$59.1K 1.05% 41
2022
Q2 		$16.9M Buy
338,600
+510
+0.2% +$27.1K 1.33% 33
2022
Q1 		$17.4M Buy
338,090
+3,100
+0.9% +$160K 1.18% 36
2021
Q4 		$16.8M Buy
334,990
+6,976
+2% +$345K 1.08% 39
2021
Q3 		$15.8M Buy
328,014
+4,977
+2% +$253K 1.1% 39
2021
Q2 		$17M Buy
323,037
+7,175
+2% +$374K 1.18% 36
2021
Q1 		$15.6M Buy
315,862
+2,918
+0.9% +$140K 1.17% 36
2020
Q4 		$15.2M Buy
312,944
+8,885
+3% +$438K 1.19% 35
2020
Q3 		$15.3M Buy
304,059
+1,560
+0.5% +$80.3K 1.37% 26
2020
Q2 		$15.4M Buy
302,499
+1,335
+0.4% +$64.9K 1.49% 21
2020
Q1 		$13.2M Sell
301,164
-400
-0.1% -$19.1K 1.55% 23
2019
Q4 		$15.1M Buy
301,564
+7,825
+3% +$367K 1.38% 27
2019
Q3 		$13.6M Buy
293,739
+200
+0.1% +$8.63K 1.34% 30
2019
Q2 		$12.7M Buy
293,539
+9,850
+3% +$419K 1.26% 35
2019
Q1 		$12.6M Sell
283,689
-2,075
-0.7% -$88.9K 1.31% 33
2018
Q4 		$12.4M Buy
285,764
+2,290
+0.8% +$101K 1.47% 28
2018
Q3 		$12.7M Buy
283,474
+5,840
+2% +$249K 1.31% 31
2018
Q2 		$11.1M Buy
277,634
+10,785
+4% +$425K 1.22% 37
2018
Q1 		$10.7M Buy
266,849
+15,800
+6% +$657K 1.19% 36
2017
Q4 		$10.8M Buy
251,049
+4,560
+2% +$210K 1.15% 38
2017
Q3 		$12.3M Buy
246,489
+8,921
+4% +$432K 1.38% 32
2017
Q2 		$11.4M Buy
237,568
+2,225
+0.9% +$106K 1.34% 31
2017
Q1 		$10.6M Sell
235,343
-140
-0.1% -$5.94K 1.32% 30
2016
Q4 		$9.52M Buy
235,483
+83,515
+55% +$3.29M 1.23% 34
2016
Q3 		$5.8M Buy
151,968
+72,583
+91% +$2.91M 0.76% 42
2016
Q2 		$3.32M Buy
+79,385
New +$3.26M 0.47% 58

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Grandfield & Dodd's SNY Position: Q2 2026 in Review

Grandfield & Dodd reduced its Sanofi (SNY) stake by 0.67% in Q2 2026, selling an estimated $116K and leaving 384,643 shares worth $16.4M. The position accounts for 0.86% of the portfolio, ranked #40.

Grandfield & Dodd first reported a position in SNY in Q2 2016 and has held it in 41 quarters since. The position peaked at $22.5M in Q3 2024. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Grandfield & Dodd held 384,643 shares of Sanofi worth $16.4M as of Q2 2026.
  • Grandfield & Dodd sold 2,587 Sanofi shares in Q2 2026, an estimated $116K.
  • Sanofi made up 0.86% of Grandfield & Dodd's portfolio in Q2 2026, its #40 holding.
  • Grandfield & Dodd first reported a position in Sanofi in Q2 2016 and has held it in 41 quarters since.
  • Grandfield & Dodd's Sanofi position peaked at $22.5M in Q3 2024.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Grandfield & Dodd's 13F filing for Q2 2026, filed 7 Aug 2026.